Log in
A biomarker is a measurement or physical sign used as a substitute for a clinically meaningful endpoint that measures directly how a patient feels, functions, or survives. Biomarkers can be used to assess changes induced by a therapy or intervention on a clinically meaningful endpoint.
New quantitative image analysis techniques developed at Imperial College have enabled the computation of imaging biomarkers that are now widely used in clinical trials as well as for healthcare diagnostics. This case study illustrates the resulting key impacts including:
The key impact of this project, in the form of `proof of concept', has been by influencing the practice of medical professionals (haematologists) at the Transfusion Medicine & Immunohematology section (in the hospital wing) of the Christian Medical College (CMC) Vellore (India). This has been achieved by developing and implementing system software for segmenting (and watermarking) of the nuclei of the White Blood Cells (WBCs) of peripheral blood smear images to overcome the challenge of identifying various pathological conditions. Segmentation of medical images is a highly challenging process, especially when dealing with blood smear images, which are known to have a very complex cell structure. The project has led to a significant improvement in the work process of haematologists at CMC's hospital wing where the output of this research (software system pilot) is being used. This has had an impact on the way smear slides are digitised, archived, and includes the segmentation, analysis, and watermarking of medical images at CMC. Christian Medical College (CMC) and Hospital at Vellore is an educational and pioneering research institute and a tertiary care hospital (which is the CMC's hospital wing), located at Tamil Nadu in Southern India.
Key advances in the earlier diagnosis of cancer, leading to better treatment and higher survival rates, have resulted from the commercialisation of unique imaging software that exploits research from the Department of Engineering Science. The software products that came from this research, Volpara™, XD and XRT are now used at major cancer centres worldwide (with approximately 1100 software installations), aiding treatment of tens of thousands of patients every year. Between 2009 and July 2013, Volpara™ scanned over 1.2 million mammograms, enabling the early detection of around 1800 cancers. The products' success has catalysed significant improvements in cancer care, and generated an estimated £9M in sales over the past two years for the spinout companies established to develop them (Matakina, based in New Zealand, and Mirada Medical, based in the UK).
SIAscopy is an image analysis method using the physics of image formation. It non-invasively provides near-instant quantitative maps of the key histological components of the skin. The scientific underpinnings were developed by Prof. Claridge's group, patented, and commercialised via a spin-off company Astron Clinica. SIAscopy was incorporated into medical imaging products which improved accuracy of general practitioners in diagnosis of melanoma, a skin cancer, whilst delivering higher cost-effectiveness than best clinical practice. Developed primarily for cancer diagnosis, SIAscopy also found uses in the cosmetics industry. In 2011 the current IPR owner, MedX, estimated the US market opportunity for the technology to be around $1 Billion.
Research undertaken at UEA developed revolutionary algorithms for making pictures look better. These algorithms were subsequently engineered into prize winning desktop and embedded applications, resulting in the creation of the spinout company, Imsense Ltd., in 2006.
In July 2010, Imsense Ltd. was acquired by [text removed for publication] and the Imsense technology has now been incorporated into [text removed for publication] product pipeline.
Researchers in the Department of Mathematics at Swansea University have developed novel geometric methods for image processing, feature extraction and shape interrogation. The research has delivered commercial and clinical impact in a variety of settings, ranging from new water marking techniques to improve piracy detection in the film industry, to medical research investigating the replacement of traditional CT scans with safer MR scans. The research has also delivered an automatic feature and gap detection tool that has been successfully applied to aircraft data files provided by BAE Systems. A consultancy company is exploiting the methods and a licence for the commercialisation of the technology is in process.
UCL's research has led to changes in patient care for men with prostate cancer, through the implementation of less invasive, image-directed treatment and diagnostic strategies, and clinical trials that use these techniques. The use of medical image registration software to deliver high- intensity ultrasound therapy in a targeted manner has been shown to change the treatment plan in half of the patients participating in a clinical study. New biopsy criteria are now used routinely to classify patient risk at University College Hospital, where, since 2009, clinicians have determined the treatment options for more than 741 prostate cancer patients. The scheme has been adopted, by 15 other hospitals in the UK and internationally, where it has become the recommended standard of care, and has been used to treat more than 1,200 patients.
The Boujou special effects software was developed from research carried out at the Department of Engineering Science. It enables sophisticated computer generated imagery (CGI) to be quickly and easily added to `real' film footage, facilitating the visual effects that feature so importantly in films such as Harry Potter and X-Men. The software has become an essential tool used by film-makers, TV advert producers, and video game manufacturers, and for instance played a pivotal role in helping `The Curious Case of Benjamin Button' win the 2009 Oscar for Best Visual Effects. Between 2008 and 2013, sales of Boujou totalled £1.37 million and this software boosted productivity and profitability right across the global digital entertainment industry.
Phase unwrapping is an essential algorithmic step in any measurement system or sensor that seeks to determine continuous phase. Instances of such devices are widespread: e.g. image reconstruction in magnetic resonance imaging (MRI), synthetic aperture radar (SAR) by satellite systems, analysis of seismic data in geophysics and optical instrumentation, to name but a few. Without successfully solving the phase unwrapping problem these instruments cannot function.
The topic is well developed and competition among algorithms is fierce. In 2012 alone, some 235 papers, most of which were describing potential new algorithms, were published in the area. But the continuing need for high-speed, automated and robust unwrapping algorithms poses a major limitation on the employability of phase measuring systems.
Working originally within the context of structured light 3D measurement systems, our research has developed new phase image unwrapping algorithms that constitute significance advances in speed, automation and robustness. The work has led to adoption by industry, as well as use in commercial and government research centres around the globe. Our approach since 2010 has been to make these algorithms freely available to end users. Third parties have gone on to translate our algorithms into other languages, widely used numerical software libraries have incorporated the algorithms and there are high profile industrial users.
This case study involves the development and implementation of novel algorithms that control the mapping of depth from a scene being imaged by a camera to an image being viewed on a stereoscopic display so as to make viewing more comfortable for the human visual system. The algorithms, developed at Durham University between 2003 and 2005: